Clofazimine and QT prolongation in the treatment of rifampicin-resistant tuberculosis: Findings of aDSM in Taiwan
Clofazimine was significantly associated with an increased risk of QTcF prolongation. QTcF≥501ms was potentially associated with fatal event and needed to be managed cautiously.
Authors
- Chen‐Yuan Chiang (ORCID: https://orcid.org/0000-0002-9291-2490)
- Jen‐Jyh Lee (ORCID: https://orcid.org/0000-0001-8073-4693)
- Yi-Wen Huang (ORCID: https://orcid.org/0000-0001-6097-3910)
- Chou-Jui Lin
- Jinhua Chen
- Chih‐Hsin Lee (ORCID: https://orcid.org/0000-0003-1492-3044)
- Ming-Chih Yu
- Chih‐Bin Lin
- Shun-Tien Chien
Institutions
- Tzu Chi University (TW)
- Taipei Medical University Hospital (TW)
- Tao Yuan General Hospital (TW)
- Ministry of Health and Welfare (TW)
- International Union Against Tuberculosis and Lung Disease (FR)
- Chest Hospital, Ministry of Health and Welfare (TW)
- Wan Fang Hospital (TW)
- Chang Hua Hospital (TW)
- Taipei Medical University (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1016/j.jmii.2024.08.002
- Citations
- 11
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 4.42